CD14 C-159T and early infection with Pseudomonas aeruginosa in children with cystic fibrosis

A.C. Martin, Ingrid Laing, G. Zhang, Siobhan Brennan, K. Winfield, Peter Sly, Stephen Stick, Jack Goldblatt, Peter Le Souef

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Early acquisition of Pseudomonas aeruginosa is associated with a poorer prognosis in patients with cystic fibrosis. We investigated whether polymorphisms in CD14, the lipopolysaccharide receptor, increase the risk of early infection. Forty-five children with cystic fibrosis were investigated with annual bronchoalveolar lavage (BAL) and plasma sCD14 levels. Plasma sCD14 levels were significantly lower in children from whom P. aeruginosa was subsequently isolated (492.75 mu g/ml vs. 1339.43 mu g/ml, p = 0.018). Those with the CD14 - 159CC genotype had a significantly increased risk of early infection with P. aeruginosa suggesting that CD14 C-159T plays a role in determining the risk of early infection with P. aeruginosa.
Original languageEnglish
Pages (from-to)1-4
JournalRespiratory Research
Volume6
Issue number1
DOIs
Publication statusPublished - 2005

Fingerprint Dive into the research topics of 'CD14 C-159T and early infection with Pseudomonas aeruginosa in children with cystic fibrosis'. Together they form a unique fingerprint.

Cite this